Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)

J D Leverson, H Zhang, J Chen, S K Tahir, D C Phillips, J Xue, P Nimmer, S Jin, M Smith, Y Xiao, P Kovar, A Tanaka, M Bruncko, G S Sheppard, L Wang, S Gierke, L Kategaya, D J Anderson, C Wong, J Eastham-Anderson, M J C Ludlam, D Sampath, W J Fairbrother, I Wertz, S H Rosenberg, C Tse, S W Elmore, A J Souers

Open source

DOI: 10.1038/cddis.2014.561
Published: 2015-01-15
Container: Cell Death & Disease
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/cddis.2014.561,
  title = {Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)},
  author = {J D Leverson and H Zhang and J Chen and S K Tahir and D C Phillips and J Xue and P Nimmer and S Jin and M Smith and Y Xiao and P Kovar and A Tanaka and M Bruncko and G S Sheppard and L Wang and S Gierke and L Kategaya and D J Anderson and C Wong and J Eastham-Anderson and M J C Ludlam and D Sampath and W J Fairbrother and I Wertz and S H Rosenberg and C Tse and S W Elmore and A J Souers},
  year = {2015},
  journal = {Cell Death \&amp; Disease},
  doi = {10.1038/cddis.2014.561},
  url = {https://doi.org/10.1038/cddis.2014.561}
}

RIS

TY  - JOUR
TI  - Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
AU  - J D Leverson
AU  - H Zhang
AU  - J Chen
AU  - S K Tahir
AU  - D C Phillips
AU  - J Xue
AU  - P Nimmer
AU  - S Jin
AU  - M Smith
AU  - Y Xiao
AU  - P Kovar
AU  - A Tanaka
AU  - M Bruncko
AU  - G S Sheppard
AU  - L Wang
AU  - S Gierke
AU  - L Kategaya
AU  - D J Anderson
AU  - C Wong
AU  - J Eastham-Anderson
AU  - M J C Ludlam
AU  - D Sampath
AU  - W J Fairbrother
AU  - I Wertz
AU  - S H Rosenberg
AU  - C Tse
AU  - S W Elmore
AU  - A J Souers
PY  - 2015
JO  - Cell Death &amp; Disease
DO  - 10.1038/cddis.2014.561
UR  - https://doi.org/10.1038/cddis.2014.561
ER  -

APA

Leverson, J. D., Zhang, H., Chen, J., Tahir, S. K., Phillips, D. C., Xue, J., Nimmer, P., Jin, S., Smith, M., Xiao, Y., Kovar, P., Tanaka, A., Bruncko, M., Sheppard, G. S., Wang, L., Gierke, S., Kategaya, L., Anderson, D. J., Wong, C., Eastham-Anderson, J., Ludlam, M. J. C., Sampath, D., Fairbrother, W. J., Wertz, I., Rosenberg, S. H., Tse, C., Elmore, S. W., & Souers, A. J. (2015). Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax). Cell Death & Disease. https://doi.org/10.1038/cddis.2014.561

Source records

crossref · retrieved 2026-09-25T11:38:29.451Z